~45 spots leftby Oct 2026

Artery Embolization for Knee Osteoarthritis

(GRAVITY Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
SA
Overseen bySiddharth A Padia, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of California, Los Angeles
Disqualifiers: Fibromyalgia, Autoimmune, Inflammatory disorder, others
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

The purpose of this clinical trial is to determine whether genicular artery embolization (GAE) is an effective way to treat knee pain from osteoarthritis. Pain from arthritis is often due to underlying inflammation in the joint. The inflammation is associated with increased abnormal blood flow going to the specific area of pain. If the investigator can reduce the blood flow, the inflammation can be reduced and the pain can be controlled. The GAE procedure is an experimental procedure to decrease the blood flow (embolize) to the specific region of the knee that is causing the pain. This will be done by infusing microscopic spheres into the specific blood vessel (genicular artery) supplying the area of pain in the knee. This is done through a procedure which is called an angiogram, which is done entirely through a pinhole at the creased of the thigh, using twilight (conscious) sedation. The investigators have already completed an initial trial at UCLA, and shown that this procedure is safe and effective. The purpose of this new trial is to compare outcomes of people undergoing the GAE procedure to those who do not undergo the procedure. A total of 100 patients will be enrolled, and 2/3 of the patients will be randomly selected to undergo the GAE procedure. 1/3 will not undergo the procedure. This is known as a randomized trial. During the trial, all subjects will also get MRIs and fluid withdrawn from their knee joints at various timepoints in order to precisely figure out how the procedure works on a closer (microscopic) level.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial requires participants to have failed conservative treatments like NSAIDs or steroid injections, it might be possible to continue some medications. Please consult with the trial coordinators for specific guidance.

What data supports the effectiveness of the treatment Genicular Artery Embolization for knee osteoarthritis?

Research shows that Genicular Artery Embolization (GAE) is a promising treatment for knee osteoarthritis, as it helps reduce pain by decreasing blood flow to inflamed areas in the knee. Studies, including systematic reviews and meta-analyses, suggest that GAE can be effective for patients whose knee pain does not improve with other treatments.12345

Is genicular artery embolization (GAE) safe for treating knee osteoarthritis?

Genicular artery embolization (GAE) is generally considered safe for treating knee osteoarthritis, with studies showing a low incidence of adverse reactions. Some patients may experience minor issues like skin bruising or temporary knee stiffness, but major complications are uncommon.14678

How is genicular artery embolization different from other treatments for knee osteoarthritis?

Genicular artery embolization (GAE) is a unique, minimally invasive treatment for knee osteoarthritis that targets the blood vessels (genicular arteries) supplying the knee to reduce pain, unlike traditional treatments that often involve medication or surgery.135910

Research Team

SA

Siddharth A Padia, MD

Principal Investigator

University of California, Los Angeles

Eligibility Criteria

This trial is for adults aged 40-79 with moderate to severe knee pain from osteoarthritis, who haven't had success with standard treatments like NSAIDs or joint injections. Participants should have a Kellgren-Lawrence score >2 and be ineligible for or refuse surgery. Exclusions include certain medical conditions, allergies, pregnancy, recent smoking history, and previous knee replacements.

Inclusion Criteria

My condition did not improve after 3 months of standard treatments like painkillers, physical therapy, or joint injections.
My X-ray shows I have moderate to severe osteoarthritis.
My knee pain is more than 5 out of 10 on a pain scale.
See 4 more

Exclusion Criteria

You have smoked cigarettes in the past year or currently smoke.
My knee X-ray shows severe OA with significant bending.
Allergy to iodinated contrast agents
See 9 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo genicular artery embolization (GAE) or are observed without intervention. GAE involves infusing microspheres into the genicular artery to reduce blood flow and inflammation.

6 months
Initial procedure followed by visits at 1, 3, and 6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment, with evaluations including MRI, serum and joint aspiration, and clinical assessments.

24 months
Follow-up visits at 12 and 24 months

Crossover

Participants in the observation group have the option to crossover to the GAE treatment arm after 6 months, with follow-up evaluations similar to initial GAE subjects.

18 months
Follow-up visits at 1, 3, 6, 12, and 24 months post-crossover

Treatment Details

Interventions

  • Genicular Artery Embolization (Embolization Agent)
Trial OverviewThe study tests if genicular artery embolization (GAE), which reduces blood flow to the painful area of the knee using Embozene MicroSpheres during an angiogram procedure, can alleviate arthritis pain compared to no intervention. It's a randomized trial where two-thirds of participants will undergo GAE and one-third will not.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: GAE TreatmentExperimental Treatment1 Intervention
Subjects will be treated with a genicular artery embolization (GAE) procedure performed with Embozene Microspheres. The microspheres will be delivered in a saline-contrast medium solution and will be delivered to the arteries supplying the areas of the subject's pain.
Group II: ObservationalActive Control1 Intervention
Subjects randomized to the observational group will not undergo the experimental GAE Treatment. PI will offer subjects enrolled into the observational group to crossover to the experimental GAE Treatment group after they have completed their 6-month follow-up assessments.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+
Dr. Thomas Rando profile image

Dr. Thomas Rando

University of California, Los Angeles

Chief Medical Officer since 2023

MD from UCLA

Amir Naiberg profile image

Amir Naiberg

University of California, Los Angeles

Chief Executive Officer since 2024

JD from UCLA

Varian Medical Systems

Industry Sponsor

Trials
63
Recruited
3,700+

Dow R. Wilson

Varian Medical Systems

Chief Executive Officer since 2012

MBA from Dartmouth's Amos Tuck School of Business, BA from Brigham Young University

Dr. Deepak Khuntia

Varian Medical Systems

Chief Medical Officer since 2020

MD from the University of Cambridge, PhD from the University of Leicester

Findings from Research

A study of 205 patients who underwent genicular artery embolization (GAE) revealed that the anatomy of the genicular arteries is complex, with various branching patterns identified, which is crucial for effective treatment of knee osteoarthritis.
Using cone-beam computed tomography (CBCT) during the procedure allows for better visualization of these arteries, helping to accurately target the right vessels for embolization and reducing the risk of affecting unintended areas.
Classification of Genicular Artery Anatomic Variants Using Intraoperative Cone-Beam Computed Tomography.Callese, TE., Cusumano, L., Redwood, KD., et al.[2023]
Genicular artery embolization (GAE) is a promising treatment for symptomatic knee osteoarthritis, showing a significant reduction in pain and symptoms over 12 months, with 68% of patients experiencing at least a 50% reduction in pain scores.
The procedure was found to be technically successful in all 40 participants, with a generally acceptable safety profile, although some patients experienced mild and transient side effects, such as skin discoloration and knee pain.
Genicular Artery Embolization for the Treatment of Symptomatic Knee Osteoarthritis.Padia, SA., Genshaft, S., Blumstein, G., et al.[2022]
Genicular artery embolization (GAE) is an effective minimally invasive treatment for knee pain due to osteoarthritis, showing significant reductions in pain scores at 1, 3, 6, and 12 months after the procedure, based on a systematic review of 10 studies involving 351 treated knees.
Patients experienced substantial declines in pain, with a Hedge's g effect size indicating strong pain relief, particularly at 6 months with a score decrease of 41 points on the Visual Analog Scale, demonstrating GAE's potential as a durable pain management option for osteoarthritis.
Genicular Artery Embolization as a Treatment for Osteoarthritis Related Knee Pain: A Systematic Review and Meta-analysis.Epelboym, Y., Mandell, JC., Collins, JE., et al.[2023]

References

Classification of Genicular Artery Anatomic Variants Using Intraoperative Cone-Beam Computed Tomography. [2023]
Genicular Artery Embolization for the Treatment of Symptomatic Knee Osteoarthritis. [2022]
Genicular Artery Embolization as a Treatment for Osteoarthritis Related Knee Pain: A Systematic Review and Meta-analysis. [2023]
Common Design, Data Elements and Core Outcome Measures Reported on Clinical Trials of Genicular Artery Embolization for Knee Osteoarthritis: An Interactive Systematic Review. [2023]
Osteoarthritis-Related Knee Pain Treated With Genicular Artery Embolization: A Systematic Review and Meta-analysis. [2022]
Multicenter Randomized Sham Controlled Study of Genicular Artery Embolization for Knee Pain Secondary to Osteoarthritis. [2022]
Genicular Artery Embolization Technique. [2023]
[Efficacy analysis of selective genicular artery embolization in the treatment of knee pain secondary to osteoarthritis]. [2022]
Cadaveric and Angiographic Anatomical Considerations in the Genicular Arterial System: Implications for Genicular Artery Embolisation in Patients with Knee Osteoarthritis. [2021]
[Embolization of genicular arteries in patients with knee osteoarthritis as an alternative for refractory pain treatment: A systematic review]. [2022]